---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-21-014235"
form_type: "8-K"
ticker: "CSBR"
cik: "0000771856"
company_name: "CHAMPIONS ONCOLOGY, INC."
filed_at: "2021-07-22T23:59:59+00:00"
generated_at: "2026-06-30T03:30:13.712385+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Champions Oncology reports record FY2021 revenue of $41M (+28% YoY); turns to operating profit of $338K

## Summary
- FY2021 revenue $41.0M, up 28% from $32.1M; Q4 revenue $10.6M, up 21% from $8.8M.
- Full-year operating income of $338K vs loss of $1.9M; Q4 operating loss narrowed to $456K from $2.0M.
- Gross margin improved to 48% (FY2021) and 47% (Q4) vs 47% and 43% a year ago.
- Cash position $4.7M with no debt; net cash used in ops $1.7M for the year.
- Launched Lumin SaaS platform; developing AI/ML-driven target discovery using proprietary datasets.

## SEC filing metadata
- accession: 0001628280-21-014235
- form_type: 8-K
- ticker: CSBR
- cik: 0000771856
- company_name: CHAMPIONS ONCOLOGY, INC.
- filed_at: 2021-07-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771856/000162828021014235/0001628280-21-014235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771856/000162828021014235/csbr-20210722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-21-014235
- JSON: https://secwatch.observer/filing/0001628280-21-014235.json
- Plain text: https://secwatch.observer/filing/0001628280-21-014235.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.